Sysalkapc Syrup contains Magnesium citrate, and Potassium citrate as main active ingredients.
Role of active ingredients:
Potassium citrate increases urinary citrate principally by modifying the renal handling of citrate, rather than by increasing the filtered load of citrate. The changes induced by potassium citrate tablets produce a urine that is less conducive to the crystallization of stone-forming salts (calcium oxalate, calcium phosphate and uric acid). Potassium citrate also inhibits the spontaneous nucleation of calcium oxalate and calcium phosphate (brushite).
Magnesium citrate inhibits the formation of calcium-oxalate crystals in the urine.
Sysalkapc Syrup is used for:
Optimal maintenance of salt balance,
Prevention and/or treatment of kidney stones,
To promote optimal kidney health,
To prevent calcium oxalate kidney stones.
Use under medical supervision.
